UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000005631 |
|---|---|
| Receipt number | R000006654 |
| Scientific Title | Phase II clinical trial of personalized peptide vaccination with low dose cyclophosphamide for standard therapy failer non-small cell lung cancer patients |
| Date of disclosure of the study information | 2011/05/23 |
| Last modified on | 2017/11/13 15:42:20 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/05/23 18:37:40 | ||
| 2 | Update | 2011/07/19 11:41:40 | Key inclusion criteria |
|
| 3 | Update | 2011/09/02 10:04:38 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 4 | Update | 2011/09/02 10:07:51 | Key inclusion criteria |
|
| 5 | Update | 2011/09/02 10:08:03 | Narrative objectives1 |
|
| 6 | Update | 2011/10/05 22:57:51 | Organization1 Tel1 Email1 |
|
| 7 | Update | 2014/07/10 17:05:40 | Last name of lead principal investigator Last name of lead principal investigator Division name Division name Address Address TEL Institute Institute Organization Organization Category of Funding Organization Nationality of Funding Organization Nationality of Funding Organization |
|
| 8 | Update | 2017/11/13 15:42:20 | Recruitment status Anticipated trial start date |
